Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Mar-24 7:21 PM View:  | Waksal Harlan Executive Chair Director | Lyra Therapeutics, Inc. (LYRA) | 18-Mar-24 | Grant | 275,000 | -- | -- | 105% 261.97K to 536.97K | |
| 13-Nov-23 5:29 PM View: | Waksal Harlan Executive Chair Director | Lyra Therapeutics, Inc. (LYRA) | 10-Nov-23 | Private Purchase | 25,000 | $2.96 | $74,095.00 | 11% 236.97K to 261.97K | |
| 02-Jun-23 4:11 PM View: | Perceptive Advisors LLC Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 31-May-23 | Private Purchase | 3,610,830 | $2.49 | $9,000,000.00 | 39% 9.15M to 12.76M | |
| 02-Jun-23 4:11 PM View: | Anderson Edward T Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 31-May-23 | Private Purchase | 1,805,420 | $2.43 | $4,387,160.00 | 43% 4.2M to 6.01M | |
| 02-Jun-23 4:15 PM View: | Nbvm Gp, LLC 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 31-May-23 | Private Purchase Duplicate | 1,805,420 | $2.43 | $4,387,160.00 | 44% 4.08M to 5.89M | |
| 02-Feb-23 5:12 PM View: | Noyes Corinne See Remarks | Lyra Therapeutics, Inc. (LYRA) | 31-Jan-23 | Grant | 36,667 | -- | -- | 100% 0 to 36.67K | |
| 02-Feb-23 5:41 PM View: | Richard Robert E. SVP, Technical Operations | Lyra Therapeutics, Inc. (LYRA) | 31-Jan-23 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 13-Jun-22 4:05 PM View: | Merrifield C Ann Director | Lyra Therapeutics, Inc. (LYRA) | 10-Jun-22 | Purchase | 4,000 | $5.05 | $20,200.00 | 55% 7.33K to 11.33K | |
| 17-May-22 5:35 PM View: | Merrifield C Ann Director | Lyra Therapeutics, Inc. (LYRA) | 16-May-22 | Purchase | 328 | $5.00 | $1,640.00 | 5% 7.0K to 7.33K | |
| 17-May-22 5:35 PM View: | Merrifield C Ann Director | Lyra Therapeutics, Inc. (LYRA) | 13-May-22 | Purchase | 3,500 | $4.81 | $16,845.50 | 100% 3.5K to 7.0K | |
| 13-Apr-22 7:16 PM View: | Waksal Harlan Executive Chair Director | Lyra Therapeutics, Inc. (LYRA) | 12-Apr-22 | Market Purchase | 236,966 | $4.22 | $999,996.00 | 100% 0 to 236.97K | < 1% |
| 14-Apr-22 4:08 PM View: | Anderson Edward T Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 12-Apr-22 | Market Purchase | 2,369,670 | $4.22 | $9,999,990.00 | 138% 1.71M to 4.08M | < 1% |
| 14-Apr-22 4:08 PM View: | Anderson Edward T Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 12-Apr-22 | Market Purchase | 118,483 | $4.22 | $499,998.00 | 3% 4.08M to 4.2M | < 1% |
| 14-Apr-22 4:14 PM View: | Nbvm Gp, LLC 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 12-Apr-22 | Market Purchase Duplicate | 2,369,670 | $4.22 | $9,999,990.00 | 138% 1.71M to 4.08M | < 1% |
| 14-Apr-22 4:53 PM View: | Perceptive Advisors LLC Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 12-Apr-22 | Market Purchase | 5,924,170 | $4.22 | $25,000,000.00 | 184% 3.22M to 9.15M | < 1% |
| 22-Jun-21 4:28 PM View: | Merrifield C Ann Director | Lyra Therapeutics, Inc. (LYRA) | 17-Jun-21 | Market Purchase | 3,500 | $8.97 | $31,394.70 | 100% 0 to 3.5K | (7%) |
| 17-Dec-20 4:05 PM View: | Snyderman Nancy Lynn Md Director | Lyra Therapeutics, Inc. (LYRA) | 16-Dec-20 | Purchase | 1,025 | $9.72 | $9,963.00 | 100% 0 to 1.02K | |
| 15-May-20 6:16 PM View: | Soleus Private Equity Gp I,... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 442,938 | -- | -- | 100% 442.96K to 885.9K | |
| 06-May-20 7:31 PM View: | Langer Robert Director | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 668 | -- | -- | 5% 14.5K to 15.17K | |
| 15-May-20 6:16 PM View: | Soleus Private Equity Gp I,... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Exercise (in-the money or at-the-money) | 31,382 | $8.63 | $270,827.00 | 3% 1.04M to 1.07M | |
| 06-May-20 7:32 PM View: | Anderson Edward T Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Purchase | 250,000 | $16.00 | $4,000,000.00 | 17% 1.44M to 1.69M | |
| 06-May-20 7:34 PM View: | Roberts Carmichael 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 415 | -- | -- | < 1% 58.0K to 58.41K | |
| 06-May-20 7:38 PM View: | Nbvm Gp, LLC 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion Duplicate | 1,442,680 | -- | -- | 100% 0 to 1.44M | |
| 06-May-20 7:38 PM View: | Nbvm Gp, LLC 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Sale Duplicate | 24,183 | $16.00 | $386,928.00 | (1%) 1.74M to 1.71M | |
| 06-May-20 7:34 PM View: | Polaris Venture Management ... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 322,920 | -- | -- | 100% 0 to 322.92K | |
| 06-May-20 7:30 PM View: | Polaris Venture Management ... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Sale | 9,674 | $16.00 | $154,784.00 | (< 1%) 1.11M to 1.1M | |
| 06-May-20 9:10 PM View: | Perceptive Advisors LLC Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Payment of Exercise | 259,346 | $16.00 | $4,149,540.00 | (9%) 2.86M to 2.6M | |
| 06-May-20 9:10 PM View: | Perceptive Advisors LLC Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Exercise (in-the money or at-the-money) | 480,825 | $8.63 | $4,149,520.00 | 20% 2.38M to 2.86M | |
| 15-May-20 6:16 PM View: | Soleus Private Equity Gp I,... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Purchase | 155,000 | $16.00 | $2,480,000.00 | 17% 885.9K to 1.04M | |
| 06-May-20 7:32 PM View: | Anderson Edward T Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Sale | 24,183 | $16.00 | $386,928.00 | (1%) 1.74M to 1.71M | |
| 06-May-20 7:38 PM View: | Nbvm Gp, LLC 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Purchase Duplicate | 250,000 | $16.00 | $4,000,000.00 | 17% 1.44M to 1.69M | |
| 06-May-20 7:38 PM View: | Nbvm Gp, LLC 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Exercise (in-the money or at-the-money) Duplicate | 44,831 | $8.63 | $386,892.00 | 3% 1.69M to 1.74M | |
| 06-May-20 7:30 PM View: | Polaris Venture Management ... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 1,030,090 | -- | -- | 100% 0 to 1.03M | |
| 06-May-20 7:30 PM View: | Polaris Venture Management ... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Exercise (in-the money or at-the-money) | 17,932 | $8.63 | $154,753.00 | 2% 1.09M to 1.11M | |
| 29-May-20 5:34 PM View: | Perceptive Advisors LLC Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Purchase | 625,000 | $16.00 | $10,000,000.00 | 24% 2.6M to 3.22M | |
| 15-May-20 6:16 PM View: | Soleus Private Equity Gp I,... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Sale | 16,909 | $16.00 | $270,544.00 | (2%) 1.07M to 1.06M | |
| 06-May-20 7:32 PM View: | Anderson Edward T Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 1,442,680 | -- | -- | 100% 0 to 1.44M | |
| 06-May-20 7:32 PM View: | Anderson Edward T Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Exercise (in-the money or at-the-money) | 44,831 | $8.63 | $386,892.00 | 3% 1.69M to 1.74M | |
| 06-May-20 7:34 PM View: | Whitesides George M Director | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 6,404 | -- | -- | 13% 48.66K to 55.06K | |
| 06-May-20 7:30 PM View: | Polaris Venture Management ... 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Purchase | 62,500 | $16.00 | $1,000,000.00 | 6% 1.03M to 1.09M | |
| 06-May-20 9:10 PM View: | Perceptive Advisors LLC Director 10% Owner | Lyra Therapeutics, Inc. (LYRA) | 05-May-20 | Conversion | 2,376,080 | -- | -- | 100% 0 to 2.38M | |
| 01-May-20 6:35 PM View: | Whitesides George M Director | Lyra Therapeutics, Inc. (LYRA) | 01-May-20 | Grant | 19,661 | $16.00 | $314,576.00 | 68% 29.0K to 48.66K |
